Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Sanofi withdraws Campath in US and EU
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
A complex role of herpes viruses in the disease process of multiple sclerosis.
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
European Congress of Immunology 2012
Genetics of multiple sclerosis: swimming in an ocean of data.
Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Safety issue puts daclizumab in doubt for MS
Ustekinumab.
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Pages